Acabal, Joan .
HRN: 23-99-08 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/03/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
12/03/2023
12/05/2023
IV
500mg
X 4 More Doses
S/p Primary CS
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: BloodstreamSkin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes